Rivaroxaban has no net clinical benefit over enoxaparin for thromboprophylaxis in acutely ill patients
Feb 6th - NEJM - Extended-duration rivaroxaban was superior to standard-duration enoxaparin for thromboprophylaxis, but was associated with increased bleeding ...